Bharat Biotech
Overview
Bharat Biotech International Limited is an Indian multinational biotechnology company engaged in drug discovery, drug development, and the manufacture of vaccines and biotherapeutics. Founded in 1996, the company is known for developing vaccines for diseases such as COVID-19 (Covaxin), Rotavirus, and Typhoid. While its primary function is as an operating company, it has engaged in limited corporate investment activity.
Portfolio Companies
3
Website
bharatbiotech.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| heva | Sep 2025 | Pre Seed | Co-investor |
| Alopexx | Sep 2024 | Strategic | Co-investor |
| Eastman Exports Global Clothing Private Limited | Dec 2022 | Early Funding | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bharat Biotech based?
Bharat Biotech is headquartered in Hyderabad, Telangana, India.
When was Bharat Biotech founded?
Founding year information for Bharat Biotech is not publicly available.
How many portfolio companies does Bharat Biotech have?
Bharat Biotech has 3 portfolio companies in Caplight's dataset.
What are some companies in Bharat Biotech's portfolio?
Recent investments visible on Caplight include heva, heva, Alopexx, Eastman Exports Global Clothing Private Limited.
What was Bharat Biotech's most recent investment?
Bharat Biotech's most recent investment on Caplight was in heva in 2025.
What sectors does Bharat Biotech focus on?
Bharat Biotech focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech.
What company stages does Bharat Biotech focus on?
Bharat Biotech typically invests at the Early stage.